Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -69.76% | -69.05% | -34.34% | -35.97% | 394.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -69.76% | -69.05% | -35.12% | -36.72% | 364.81% |
| Cost of Revenue | -14.27% | -12.26% | -17.17% | -19.21% | -11.83% |
| Gross Profit | -188.16% | -190.22% | 3.99% | 6.36% | 157.29% |
| SG&A Expenses | -12.83% | -10.79% | -4.85% | -7.20% | -7.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.70% | -11.68% | -12.51% | -14.67% | -10.12% |
| Operating Income | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| Income Before Tax | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| EBIT | -421.46% | -433.65% | 4.43% | 6.79% | 87.62% |
| EBITDA | -506.59% | -520.88% | 4.09% | 6.45% | 89.36% |
| EPS Basic | -425.00% | -437.50% | 5.00% | 6.56% | 88.06% |
| Normalized Basic EPS | -420.00% | -440.00% | 5.26% | 5.26% | 88.10% |
| EPS Diluted | -425.00% | -450.00% | 12.12% | 14.93% | 88.06% |
| Normalized Diluted EPS | -420.00% | -440.00% | 5.26% | 5.26% | 88.10% |
| Average Basic Shares Outstanding | 1.30% | 1.30% | 0.62% | 0.62% | 0.56% |
| Average Diluted Shares Outstanding | 1.30% | 1.30% | 0.62% | 0.62% | 0.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |